Invivyd Inc. (IVVD)
IVVD trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.6460
-4.05% on the day
Market cap
$190.4M
Micro cap
Revenue · 2025
$53.4M
+110.5% on 2024
Net income · 2025
-$52.5M
-98.2% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | IVVD on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001832038 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $53.4M |
| Net income | -$52.5M |
| Operating income | -$55.6M |
| Net margin | -98.2% |
| Operating margin | -104.0% |
| Revenue growth | +110.5% |
| Cash | $226.7M |
| Total assets | $276.9M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 3.6× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2025-11-19 |
| Latest annual report | 10-K | 2026-03-05 |
| Latest quarterly / interim | 10-Q | 2026-08-13 |
| Latest current report | 8-K | 2026-09-29 |
| Latest proxy | DEFA14A | 2026-04-06 |
Source: SEC EDGAR submissions feed, 448 recent filings. All filings on EDGAR.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CGEN | Compugen Ltd. | $1.98 | -4.35% | $187.3M |
| STRO | Sutro Biopharma Inc. | $11.01 | -17.09% | $182.6M |
| ALEC | Alector Inc. | $1.87 | -10.10% | $208.8M |
| DTIL | Precision BioSciences Inc. | $6.10 | -6.58% | $168.4M |
| CHRS | Coherus Oncology Inc. | $1.07 | +3.88% | $165.3M |
| IPHA | Innate Pharma S.A. ADS | $1.47 | -0.68% | $164.2M |
| PLX | Protalix BioTherapeutics Inc. (DE) | $2.75 | -1.08% | $221.6M |
| LXEO | Lexeo Therapeutics Inc. | $2.74 | -9.87% | $224.8M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier